During a live event, Matthew Lunning, DO, discussed key factors that determine whether patients should receive CAR T-cell ...
Erika Mayer, MD, MPH, Dana-Farber Cancer Institute, discusses the exciting findings of the phase 3 lidERA study investigating ...
Sacituzumab govitecan shows improved survival and quality of life in advanced triple-negative breast cancer, outperforming ...
Are you ready to practice medicine on your own terms but feel overwhelmed by the business side of independence? You’re not ...
According to Ira Zackon, MD, a hematologist-oncologist and senior medical director at Ontada, a retrospective study of over ...
The FDA's fast track designation acknowledges the combination's promising early efficacy and safety profile in treating MSS mCRC. Early data from a phase 1b/2 study showed deep, durable responses with ...
A study reveals the gut microbiome's role in predicting multiple myeloma outcomes, highlighting butyrate-producing bacteria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback